Monday, January 22, 2024

CalciMedica Gets $55M In Private Placement

La Jolla-based biopharmaceuticals developer CalciMedica, which trades on the NASDAQ as CALC, says it is in a private placement deal that will provide up to $55M to the company. According to the company, the private placement gives it $20.4M in upfront financing, and up to an additional $34.2M. The company said the PIPE should "be sufficient" to fund the company through subsequent clinical trials on its acute pancreatitis (AP) and AKI programs. The funding came from Deerfield Management, Soleus Capital, Stonepine Capital Management and Aisling Capital, as well as existing investors Sanderling Ventures and Bering Capital.

---